People with metabolic syndrome are at higher risk of Parkinson’s disease Analysis found greater risk ranging from 29% to 40% The syndrome already increases risk of heart disease, stroke and type 2 ...

Overview: With FDA approval of its development plan, Dei BioPharma edges closer to offering diabetes and obesity treatments ...